Zalcberg J - Search Results

1

Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumors.

Talbot SM, Westerman DA, Grigg AP, Toner GC, Wolf M, Bishop J, McKendrick J, Zalcberg J, Levi J, Fox RM, Green MD. Talbot SM, et al. Among authors: zalcberg j. Ann Oncol. 1999 Aug;10(8):907-14. doi: 10.1023/a:1008353522601. Ann Oncol. 1999. PMID: 10509151 Free article. Clinical Trial.

2

Carboplatin-containing regimens for small cell lung cancer: implications for management in the elderly.

Raghavan D, Bishop JF, Stuart-Harris R, Zalcberg J, Morstyn G, Kefford RF, Matthews JP. Raghavan D, et al. Among authors: zalcberg j. Semin Oncol. 1992 Feb;19(1 Suppl 2):12-6. Semin Oncol. 1992. PMID: 1329217

3

Recent advances in the treatment of colorectal cancer.

Wirth A, Green M, Penfold C, Hurley R, Matthews J, Burns I, Zalcberg J. Wirth A, et al. Among authors: zalcberg j. Aust N Z J Med. 1992 Feb;22(1):61-8. doi: 10.1111/j.1445-5994.1992.tb01713.x. Aust N Z J Med. 1992. PMID: 1580867 Review. No abstract available.

4

Phase II study of 10-EdAM in patients with squamous cell carcinoma of the head and neck, previously untreated with chemotherapy.

Green MD, Sherman P, Zalcberg J. Green MD, et al. Among authors: zalcberg j. Invest New Drugs. 1992 Apr;10(1):31-4. doi: 10.1007/BF01275477. Invest New Drugs. 1992. PMID: 1607252 Clinical Trial.

5

Adjuvant therapy of colorectal cancer: an overview.

Wirth A, Green M, Zalcberg JR. Wirth A, et al. Among authors: zalcberg jr. Aust N Z J Surg. 1991 Jan;61(1):13-22. doi: 10.1111/j.1445-2197.1991.tb00119.x. Aust N Z J Surg. 1991. PMID: 1994878 Review.

6

Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancer.

Bishop JF, Kefford R, Raghavan D, Zalcberg J, Stuart-Harris R, Ball D, Olver IN, Friedlander M, Bull C, Yuen K, et al. Bishop JF, et al. Among authors: zalcberg j. Cancer Chemother Pharmacol. 1990;25(5):367-70. doi: 10.1007/BF00686239. Cancer Chemother Pharmacol. 1990. PMID: 2155064

7

Lean body mass, body surface area and epirubicin kinetics.

Cosolo WC, Morgan DJ, Seeman E, Zimet AS, McKendrick JJ, Zalcberg JR. Cosolo WC, et al. Among authors: zalcberg jr. Anticancer Drugs. 1994 Jun;5(3):293-7. doi: 10.1097/00001813-199406000-00005. Anticancer Drugs. 1994. PMID: 7919453 Clinical Trial.

8

ZD1694: A novel thymidylate synthase inhibitor with substantial activity in the treatment of patients with advanced colorectal cancer. Tomudex Colorectal Study Group.

Zalcberg JR, Cunningham D, Van Cutsem E, Francois E, Schornagel J, Adenis A, Green M, Iveson A, Azab M, Seymour I. Zalcberg JR, et al. J Clin Oncol. 1996 Mar;14(3):716-21. doi: 10.1200/JCO.1996.14.3.716. J Clin Oncol. 1996. PMID: 8622016 Clinical Trial.

9

A phase II study in advanced breast cancer: ZD1694 ('Tomudex') a novel direct and specific thymidylate synthase inhibitor.

Smith I, Jones A, Spielmann M, Namer M, Green MD, Bonneterre J, Wander HE, Hatschek T, Wilking N, Zalcberg J, Spiers J, Seymour L. Smith I, et al. Among authors: zalcberg j. Br J Cancer. 1996 Aug;74(3):479-81. doi: 10.1038/bjc.1996.386. Br J Cancer. 1996. PMID: 8695369 Free PMC article. Clinical Trial.

10

'Tomudex' (ZD1694): a novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours. 'Tomudex' International Study Group.

Cunningham D, Zalcberg J, Smith I, Gore M, Pazdur R, Burris H 3rd, Meropol NJ, Kennealey G, Seymour L. Cunningham D, et al. Among authors: zalcberg j. Ann Oncol. 1996 Feb;7(2):179-82. doi: 10.1093/oxfordjournals.annonc.a010546. Ann Oncol. 1996. PMID: 8777175 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

395 results

Search Page